CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Announce Third Quarter Results on November 2, 2023

23 Oct 2023 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

19 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Presents Baseline Characteristics From SEQUOIA-HCM at the HCM Society Scientific Sessions

06 Oct 2023 12:45:00 By Nasdaq GlobeNewswire

Cytokinetics to Host Virtual Investor & Analyst Day on October 19, 2023

05 Oct 2023 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

04 Oct 2023 09:49:12 By NetDania Notify

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

03 Oct 2023 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

03 Oct 2023 10:20:20 By NetDania Notify

Cytokinetics Announces Upcoming Presentations at the 2023 HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

02 Oct 2023 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

02 Oct 2023 11:26:54 By NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

28 Sep 2023 09:47:33 By NetDania Notify

Cytokinetics Announces Call for Proposals for Its Sixth Annual Communications Grant Program

28 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

27 Sep 2023 13:39:42 By NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

26 Sep 2023 09:46:14 By NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

25 Sep 2023 09:49:39 By NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

21 Sep 2023 11:24:33 By NetDania Notify

Cytokinetics to Participate in Upcoming Investor Conferences

07 Sep 2023 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Start of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

06 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Sep 2023 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Reports Second Quarter 2023 Financial Results

03 Aug 2023 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

02 Aug 2023 09:57:28 By NetDania Notify